IGC Appoints Medical
IGC Appoints Medical Advisor Craig Cheifetz, M.D. to Consult on the Development of Cannabis-Based, Combination Therapies
May 16, 2017 09:57 ET | India Globalization Capital
BETHESDA, Md., May 16, 2017 (GLOBE NEWSWIRE) -- India Globalization Capital Inc. (NYSE MKT:IGC) announces that Craig Cheifetz, M.D. has joined the company as an advisor to provide guidance on...
NYSE MKT Extends Ind
NYSE MKT Extends India Globalization Capital Compliance Plan Period
April 21, 2017 17:30 ET | India Globalization Capital
BETHESDA, Md., April 21, 2017 (GLOBE NEWSWIRE) -- India Globalization Capital Inc. (NYSE MKT:IGC) announces that on April 20, 2017 it received notice from NYSE MKT LLC (“the Exchange”) that it has...
IGC Launches Phytoca
IGC Launches Phytocannabinoid Development Committee to Secure Preclinical Initiatives for IGC-501, IGC-502 and IGC-504
February 13, 2017 06:00 ET | India Globalization Capital
BETHESDA, Md., Feb. 13, 2017 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE-MKT:IGC) announces today that its Phytocannabinoid Development Committee has started its review of...
IGC Expands Phytocan
IGC Expands Phytocannabinoid IP Portfolio with Patent Filing for Method & Composition for Treating Seizure Disorders
June 20, 2016 08:00 ET | India Globalization Capital
BETHESDA, Md., June 20, 2016 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE:IGC) announces today that it has filed a patent related to compositions and methods for treating multiple...
IGC Files Internatio
IGC Files International Applications for Cannabinoid Composition and Method Patents
March 15, 2016 08:30 ET | India Globalization Capital
Bethesda, Md, March 15, 2016 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (IGC) announces today that it has expanded the scope of its patent strategy to include international patent...
IGC Files Preliminar
IGC Files Preliminary Phytocannabinoid Patent For Seizure Indication
June 23, 2015 08:20 ET | India Globalization Capital
June 23, 2015 (GLOBE NEWSWIRE) - IGC, Inc. (NYSE-MKT: IGC) announces that the company applied for a provisional patent based on a novel therapy that uses extracts from the cannabis plant for the...